FDA and Patent Strategies for Life Sciences Innovators

Life sciences innovators at all stages seek patent protection to limit market competition and, in some cases, attract further investment. Careful IP planning is especially important in the life sciences, with many companies relying on a handful of patents to protect their high-value products. It is essential that companies pay close attention to the interrelationship between patent and US Food and Drug Administration (FDA) regulatory considerations to protect their most valuable assets for the long term.